首页> 外国专利> Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or VCAM inhibitor for treatment of asthma or chronic obstructive pulmonary disease

Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or VCAM inhibitor for treatment of asthma or chronic obstructive pulmonary disease

机译:脱氢表雄酮或硫酸脱氢表雄酮硫酸盐与酪氨酸激酶抑制剂,δ阿片受体拮抗剂,神经激肽受体拮抗剂或VCAM抑制剂的组合用于治疗哮喘或慢性阻塞性肺疾病

摘要

A pharmaceutical or veterinary composition, comprises a first active agent selected from a dehydroepiandrosterone and/or dehydroepiandrosterone-sulfate, or a salt thereof, and a second active agent comprising a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or VCAM inhibitor for the treatment of asthma, chronic obstructive pulmonary disease, or other respiratory diseases. The composition is provided in various formulations and in the form of a kit. The products of this patent are applied to the prophylaxis and treatment of asthma, chronic obstructive pulmonary disease, or other respiratory diseases.
机译:药物或兽用组合物,其包含选自脱氢表雄酮和/或脱氢表雄酮硫酸盐或其盐的第一活性剂,以及包含酪氨酸激酶抑制剂,δ阿片样物质受体拮抗剂,神经激肽受体拮抗剂或VCAM抑制剂的第二活性剂。用于治疗哮喘,慢性阻塞性肺疾病或其他呼吸系统疾病。该组合物以各种制剂和试剂盒的形式提供。该专利的产品用于预防和治疗哮喘,慢性阻塞性肺疾病或其他呼吸道疾病。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号